Navigation Links
Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2
Date:5/23/2013

SAN DIEGO y PARÍS, 24 de mayo de 2013 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC), un destacado desarrollador y fabricante de herramientas de precisión para terapia guiadas diseñadas para mejorar la diagnosis y tratamiento de la enfermedad vascular periférica y coronaria, anunció hoy los resultados preliminares del ensayo ADVISE (Adenosine Vasodilator Independent Stenosis Evaluation) II durante la sesión de ensayo clínico hot line late breaking de EuroPCR 2013. Estos resultados prospectivos conforman los de las publicaciones retrospectivas anteriores, demostrando la utilidad clínica de una aproximación iFR®/Fractional Flow Reserve (FFR) Hybrid para simplificar la evaluación de las lesiones y ahorrar el uso de fármacos hiperémicos en un número considerable de pacientes. También se anunció que esta estrategia Hybrid iFR®/FFR, junto a la guía de ultrasonidos intravasculares (IVUS), se usará en el ensayo multicentro SYNTAX2 en Europa, que comienza a finales de este año.

"Un paso importante dentro de la validación de cualquier nueva tecnología es la identificación de una hipótesis basada en las observaciones, y su posterior prueba de las hipótesis en un gran número de centros para ver si las observaciones se traducen a la práctica en el mundo real", afirmó el doctor Javier Escaned, PhD y cardiólogo intervencional del Hospital Clínico San Carlos, Madrid, España. "El ensayo ADVISE II es el primer test prospectivo del auténtico algoritmo iFR que es analizado por medio de un laboratorio central de psicología independiente (Cardialysis, Rótterdam, Países Bajos). Estos resultados preliminare
'/>"/>

SOURCE Volcano Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Volcano Corporation Presentation At JMP Securities Conference To Be Webcast
2. Volcano to Highlight its Leadership in Precision Guided Therapy at EuroPCR 2012
3. Volcano Corporation Presentation At Jefferies Conference To Be Webcast
4. Volcano Corporation Presentation at Wells Fargo Conference to be Webcast
5. Volcano Corporation Schedules Second Quarter Conference Call, Webcast
6. Volcano Corporation Reports 13 Percent Growth In Second Quarter Revenues; FFR Disposable Revenues Increase 38 Percent
7. Volcano Corporation Presentation At Canaccord Genuity Conference To Be Webcast
8. FAME 2 Published in the New England Journal of Medicine, Volcano participates in the $84M NIH-Sponsored ISCHEMIA Trial
9. Volcano Corporation Presentation At Stifel Nicolaus Conference To Be Webcast
10. Volcano Announces Previous St. Jude Medical Products Infringe Volcano Patent and Jury Verdicts in Patent Trials with St. Jude Medical
11. Volcano Corporation Schedules Third Quarter Conference Call, Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... 2015  MEI Pharma, Inc. (Nasdaq: MEIP ), ... therapies for cancer, announced today that Daniel P. Gold ... the Cowen and Company 35 th Annual Health Care ... time from the Boston Marriott Copley Place. A live webcast ... A replay will be available approximately one hour after the ...
(Date:2/26/2015)... , February 26, 2015 ABIVAX, a ... human vaccines, today announced that it has dosed in ... Phase IIb/III clinical trial of ABX203 which is taking place ... region. The study is designed to assess whether ABX203 can ... B (CHB) via controlling viral load for a much longer ...
(Date:2/26/2015)... Feb. 26, 2015 ANSYS (NASDAQ: ... manufacturer of diesel engines and global power leader, Cummins ... broad access to the ANSYS ® portfolio. This ... solve some of the industry,s most challenging multiphysics problems ... innovative products on the market. The multi-year ...
Breaking Medicine Technology:MEI Pharma to Present at Cowen and Company Health Care Conference 2MEI Pharma to Present at Cowen and Company Health Care Conference 3ABIVAX Recruits First Patient in a Pivotal Phase IIb/III Clinical Trial with ABX203, a Novel Immunotherapy Against Chronic Hepatitis B 2ABIVAX Recruits First Patient in a Pivotal Phase IIb/III Clinical Trial with ABX203, a Novel Immunotherapy Against Chronic Hepatitis B 3ABIVAX Recruits First Patient in a Pivotal Phase IIb/III Clinical Trial with ABX203, a Novel Immunotherapy Against Chronic Hepatitis B 4ABIVAX Recruits First Patient in a Pivotal Phase IIb/III Clinical Trial with ABX203, a Novel Immunotherapy Against Chronic Hepatitis B 5Cummins Standardizes On ANSYS Engineering Simulation Software 2Cummins Standardizes On ANSYS Engineering Simulation Software 3
(Date:2/26/2015)... As the great passage beyond midlife ... meaning, more substantial roles and connections that span the ... live a life that still matters? As The Aspen ... Next Year Total Immersion Retreat , answers to these ... results and jump-starts a healthier life. A new round ...
(Date:2/26/2015)... Imagine a day without access to clean, ... and there was no one to help. For more than ... In 2015, more than 2.5 billion people will also lack ... A new initiative led by Nevada’s Desert Research Institute ... specifically on women – who often bear the brunt of ...
(Date:2/26/2015)... The COR HEALTH division of Vets Access, ... to offer customers a full line of Topricin® pain ... and effectively address muscle, joint, and nerve pain. ... LLC, Montrose, MI, that is dedicated to providing natural, ... is a research and development leader in topical natural ...
(Date:2/26/2015)... 26, 2015 The Reproductive Science Center ... newly renovated office in Lawrenceville, NJ. , ... of New Jersey’s physicians, and NJ Top Docs, have ... in the areas of infertility and reproductive medicine. This ... success rates and providing current, high quality medical treatments ...
(Date:2/26/2015)... CA (PRWEB) February 26, 2015 Beckman ... “Diversity of extracellular vesicles and their cargo in cell-to-cell ... vesicles and their relevance for cell-to-cell communication. The webinar ... March 4, 2015 at 8:00am PT. , Every cell ... extracellular vesicles (EVs) , often called “exosomes” or “microvesicles.” ...
Breaking Medicine News(10 mins):Health News:The Aspen Club on Actively Aging: Telling a New Story on Aging 2Health News:DRI launches Global Initiative to Provide Women in Developing Countries with Clean Water 2Health News:DRI launches Global Initiative to Provide Women in Developing Countries with Clean Water 3Health News:COR HEALTH Division of Vets Access Partners with Topical BioMedics to Provide Natural Pain Relief Products 2Health News:COR HEALTH Division of Vets Access Partners with Topical BioMedics to Provide Natural Pain Relief Products 3Health News:RSCNJ Is Celebrating the Reopening of Their Newly Renovated Office 2Health News:RSCNJ Is Celebrating the Reopening of Their Newly Renovated Office 3Health News:Beckman Coulter Webinar Series Presents Diversity of Extracellular Vesicles and Their Cargo in Cell-to-cell Communication 2Health News:Beckman Coulter Webinar Series Presents Diversity of Extracellular Vesicles and Their Cargo in Cell-to-cell Communication 3
... are addicted to glucose to generate their energy, but new ... rely on fatty acid metabolism to grow and to evade ... cells vulnerable to drugs that force them to commit suicide, ... Center and The University of Texas Medical School at Houston ...
... be a problem among today,s youth. While many children ... prevalent in children that are different from the social ... of bullying, research shows a high rate of sexual ... A new study conducted by doctors at Nationwide Children,s ...
... ... Center to provide financial assistance to breast cancer patients. , ... Mesa, AZ (PRWEB) January 27, 2010 -- ... Inc. to launch a vehicle and boat donation program. The Processing Center allows TBCS ...
... , , Society of Interventional Radiology Member ... A. Nemcek Jr., M.D., FSIR, in January 2011 ... Ziv J Haskal, M.D., FSIR, has been named editor of the ... Radiology (JVIR)—for a five-year term beginning in January 2011 . ...
... and Centre for Molecular Medicine and Therapeutics have uncovered ... in Huntington,s disease, and identified a possible treatment for ... published online today and will appear in the January ... Huntington,s disease is an inherited degenerative brain disease that ...
... ... why your company should win. , ... Valencia, CA (Vocus) Jan. 27, 2010 -- U.S. HealthWorks Medical Group, a leading nationwide ... businesses who want to offer an added employee benefit by getting workers vaccinated against H1N1., ...
Cached Medicine News:Health News:Researchers find leukemia cells metabolize fat to avoid cell death 2Health News:Researchers find leukemia cells metabolize fat to avoid cell death 3Health News:Study examines sexual orientation and bullying among adolescents 2Health News: The Breast Cancer Society Launches Vehicle Donation Program 2Health News: The Breast Cancer Society Launches Vehicle Donation Program 3Health News:New Editor Named for Prestigious Journal of Vascular and Interventional Radiology 2Health News:New Editor Named for Prestigious Journal of Vascular and Interventional Radiology 3Health News:New Editor Named for Prestigious Journal of Vascular and Interventional Radiology 4Health News:New Editor Named for Prestigious Journal of Vascular and Interventional Radiology 5Health News:Discovery of mechanism in brain cell injury in Huntington's offers new treatment approaches 2Health News:Twitter Contest: Free, Onsite H1N1 Vaccination Day for Winning Businesses 2
Slick® Disposable Endotracheal Stylet, Nylon-coated wire, Malleable core, Sureloc Stop helps maintain desired length for patient safety. Handle forming capability for better grip. Sterile. Single...
... spine manipulation. Prevent dental and soft tissue ... alternative to X-ray. Light-guided intubation is based ... in the neck. This technique takes advantage ... relative to the esophagus. A well-defined, circumscribed ...
All endotracheal accessories are designed to ensure your technique. The Blue Line® intubation stylets feature a satin-smooth coating and are available in three sizes....
... of flexible lighting products. The first is ... different sizes 5", 10", and 15" (refers ... light). These lights are for use in ... ,The second group of flexible lights is ...
Medicine Products: